Genomic Cancer Panel and Profiling Market Size, Share, Trend Report 2026 to 2035
Segmentation of Genomic Cancer Panel and Profiling Market :
Genomic Cancer Panel and Profiling Market By Tissue Testing-
- Solid Tissue Testing
- Liquid Tissue Testing
Genomic Cancer Panel and Profiling Market By Cancer Panel Type-
- Single-Gene Panel
- Multi-Gene Panel
Genomic Cancer Panel and Profiling Market By Cancer Type-
- Lung Cancer
- Breast Cancer
- Colon Cancer
- Prostate Cancer
- Other Cancers
Genomic Cancer Panel and Profiling Market By Application-
- Clinical
- Research
Genomic Cancer Panel and Profiling Market By Technology-
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In-Situ Hybridization (FISH)
- Immunohistochemistry (IHC)
- Others
Genomic Cancer Panel and Profiling Market By End User-
- Hospitals
- Clinical and Diagnostic Laboratories
- Research and Academic Institutes
Genomic Cancer Panel and Profiling Market By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genomic Cancer Panel and Profiling Market Snapshot
Chapter 4. Global Genomic Cancer Panel and Profiling Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Tissue Testing Estimates & Trend Analysis
5.1. By Tissue Testing, & Market Share, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Tissue Testing:
5.2.1. Solid Tissue Testing
5.2.2. Liquid Tissue Testing
Chapter 6. Market Segmentation 2: By Cancer Panel Type Estimates & Trend Analysis
6.1. By Cancer Panel Type & Market Share, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Cancer Panel Type:
6.2.1. Single-Gene Panel
6.2.2. Multi-Gene Panel
Chapter 7. Market Segmentation 3: By Cancer Type Estimates & Trend Analysis
7.1. By Cancer Type & Market Share, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Cancer Type:
7.2.1. Lung Cancer
7.2.2. Breast Cancer
7.2.3. Colon Cancer
7.2.4. Prostate Cancer
7.2.5. Other Cancers
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By End-User:
8.2.1. Hospitals
8.2.2. Clinical and Diagnostic Laboratories
8.2.3. Research and Academic Institutes
8.2.4. Other End Users
Chapter 9. Market Segmentation 5: By Technology Estimates & Trend Analysis
9.1. By Technology & Market Share, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Technology:
9.2.1. Next-Generation Sequencing (NGS)
9.2.2. Polymerase Chain Reaction (PCR)
9.2.3. Fluorescence In-Situ Hybridization (FISH)
9.2.4. Immunohistochemistry (IHC)
9.2.5. Others
Chapter 10. Market Segmentation 6: By Application Estimates & Trend Analysis
10.1. By Application & Market Share, 2025 & 2035
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Application:
10.2.1. Clinical
10.2.2. Research
Chapter 11. Genomic Cancer Panel and Profiling Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Tissue Testing, 2022-2035
11.1.2. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Panel Type, 2022-2035
11.1.3. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Type, 2022-2035
11.1.4. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By End-User, 2022-2035
11.1.5. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Technology, 2022-2035
11.1.6. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Application, 2022-2035
11.1.7. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts by country, 2022-2035
11.2. Europe
11.2.1. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2022-2035
11.2.2. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2022-2035
11.2.3. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2022-2035
11.2.4. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2022-2035
11.2.5. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2022-2035
11.2.6. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2022-2035
11.2.7. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035
11.3. Asia Pacific
11.3.1. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2022-2035
11.3.2. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2022-2035
11.3.3. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2022-2035
11.3.4. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2022-2035
11.3.5. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2022-2035
11.3.6. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2022-2035
11.3.7. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035
11.4. Latin America
11.4.1. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2022-2035
11.4.2. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2022-2035
11.4.3. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2022-2035
11.4.4. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2022-2035
11.4.5. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2022-2035
11.4.6. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2022-2035
11.4.7. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035
11.5. Middle East & Africa
11.5.1. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2022-2035
11.5.2. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2022-2035
11.5.3. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2022-2035
11.5.4. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2022-2035
11.5.5. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2022-2035
11.5.6. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2022-2035
11.5.7. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Agilent Technologies, Inc.
12.2.2. ARUP Laboratories
12.2.3. Burning Rock DX
12.2.4. Caris Life Sciences
12.2.5. Thermo Fisher Scientific, Inc.
12.2.6. Danaher Corporation (Integrated DNA Technologies, Inc.)
12.2.7. Exact Sciences Corporation
12.2.8. F. Hoffmann-La Roche Ltd
12.2.9. Fulgent Genetics
12.2.10. Genecast Biotechnology Co., Ltd
12.2.11. Illumina, Inc.
12.2.12. Invitae Corporation
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Genomic Cancer Panel and Profiling Market Size is valued at USD 10.56 Bn in 2025 and is predicted to reach USD 23.39 Bn by the year 2035
Genomic Cancer Panel and Profiling Market is expected to grow at a 8.4% CAGR during the forecast period for 2026 to 2035.
Agilent Technologies, Inc., ARUP Laboratories, Burning Rock DX, Caris Life Sciences, Thermo Fisher Scientific, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Genecast Biotechnology Co., Ltd, Illumina, Inc., Invitae Corporation, Qiagen N.V., NeoGenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Predictive Oncology, Inc., NanoString Technologies, Inc., Guardant Health, Inc., Foundation Medicine, Genscript Biotech Corporation, Tempus Labs, Hologic, Inc., and Others
Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer, Other Cancers), Application, Technology and End User.
North American region is leading the Genomic Cancer Panel and Profiling Market.